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Abstract. We have developed a typing system using natural sequence variation in the thrombospondin-related
adhesive protein (TRAP) gene of Plasmodium falciparum. This method permits a haplotype to be assigned to any
particular TRAP gene. We have applied this method to a hospital-based, case control-study in Mali. Previous sequence
variation and conservation in TRAP has been confirmed. Particular TRAP haplotypes can be used as geographic
hallmarks. Because of the high level of conflict between characters, we have examined the phylogenetic relationships
between parasites using a network approach. Having received patient samples from urban and periurban areas of
Bamako, the majority of haplotypes were closely related and distinct from TRAP sequences present in other conti-
nents. This suggests that the structure of TRAP can only tolerate a limited number of sequence variations to preserve
its function but that this is sufficient to allow the parasite to evade the host’s immune system until a long-lived
immune response can be maintained. It may also reflect host genetics in that certain variants may escape the host
immune response more efficiently than others. For vaccine design, sequences from the major regional variants may
need to be considered in the production of effective subunit vaccines.
The thrombospondin-related adhesive protein (TRAP)
gene of Plasmodium falciparum was first described in 1988.1
The gene derives its name from the deduced protein se-
quence that contains two amino acid motifs found in the
adhesive host glycoprotein thrombospondin.2 One of these
motifs is based on the amino acid sequence Glu-Trp-Ser-Pro-
Cys-Ser-Val-Thr-Cys-Gly-Lys-Gly-Thr-Arg-Ser-Arg-Lys-
Arg, which has been demonstrated to allow TRAP to bind
to sulfatide.3 The protein is present in sporozoites and eryth-
rocytic-stage parasites.4, 5 Antibodies against TRAP inhibit
sporozoite invasion.3 Recent data demonstrate that TRAP is
expressed in mature, salivary gland sporozoites but not in
hemocoel sporozoites, suggesting that TRAP may be one of
the unidentified accessory molecules required for infection
of the vertebrate host.6
Data from a longitudinal and prospective study showed
that the immune response to TRAP is long-lived in adults
and older children but short-lived in young children.7 There
were seasonal fluctuations of the levels of specific antibod-
ies, as well as age-dependent quantitative differences.7 These
data, together with that for the TRAP homolog sporozoite
surface protein 2 (SSP2) from P. yoelii, suggesting that
adoptive transfer of a CD81 cytotoxic T cell clone recogniz-
ing SSP2 gave complete protection against P. yoelii infec-
tion, suggest that TRAP would be an important component
of a multi-subunit malaria vaccine.8 Further evidence for this
has been the identification of a cytotoxic T lymphocyte re-
sponse to certain conserved epitopes in TRAP.9, 10
A major problem in the design of any malaria vaccine is
which antigens to choose and which variants of these anti-
gens are relevant. We have previously shown that TRAP is
polymorphic and that all the nucleotide changes occurring
outside what appeared to be a conserved core, containing
the sulfatide-binding motif, resulted in amino acid changes.11
The significance of this high degree of sequence variation is
not known but it does suggest that host immune response
may be a factor since the sequence of TRAP genes from
parasites in culture appear to be stable.11 The parasites in
this earlier study were from different geographic locations,
apart from the three that were from children in the Gambia.
The three Gambian sequences were closely related to each
other, but nevertheless different. The most closely related
gene sequences were from the parasite clones Dd2 (Indo-
china) and HB3A (Honduras). This report describes the ge-
netic variation of the TRAP gene in Mali from samples col-
lected during the 1992 malaria season from children (age
range 5 1–12 years) with mild and severe malaria.
PATIENTS, MATERIALS, AND METHODS
Study area and population. The study was carried out
in Bamako, the principal city of Mali. All patients were re-
cruited in the pediatric ward of the Gabriel Toure Hospital,
which is located in the center of the city. An average of
3,200 children are admitted annually to this ward. Severe
malaria cases account for 8% of all children admitted to this
hospital; 23% of these cases prove fatal. The age range of
the children in the study was 1–12 years. Blood samples
were collected from September to November 1992. Malaria
is seasonal in Mali, and the rainy season is from June to
October, which corresponds to the period of maximal inci-
dence of severe malaria in the study area. Malaria inocula-
tion rates range one to 10 per person per year in urban areas,
and from 50 and 200 in the surrounding rural villages.12, 13
Anopheles gambiae, A. arabiensis, and A. funestus are the
main malaria vectors in this part of Africa. The great ma-
jority of the population belongs to the Bambara ethnic group,
with Fulani and Senoufu being in the minority. Parental con-
sent was obtained for participation of all the children in the
study, which was approved by the National Ethical Com-
mittee of the Ministry of Health of Mali. The modified Glas-
gow coma scale to be applicative to children, including those
who have not learned to speak,14 was used in assessing se-
vere malaria. Children having a coma score between 0 and
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FIGURE 1. Schematic representation of the structure of the the thrombospondin-related protein (TRAP) gene of Plasmodium falciparum
and the strategy for the different polymerase chain reactions. The sequences of the oligonucleotide primers are given at the bottom of the
Figure. TRAP1 and TRAP2 contain Bam HI sites at their 59 ends, TRAP1 corresponds to nucleotides (306-326), and TRAP2 to nucleotides
(1979-2000) in the T9/96 sequence. The relative positions of the polymorphic restriction enzyme sites are shown. RGD 5 Arg-Gly-Asp.
2 were comatose. Children having a positive blood smear
for P. falciparum, a body temperature greater than 37.58C,
and showing no signs of impaired consciousness were con-
sidered to have mild malaria. Children with patent bacterial
infection and/or a history of repeated convulsions were ex-
cluded from the study. All children admitted to the study
were treated according to World Health Organization
(WHO) guidelines using drugs that were available free of
charge as part of the study.
Blood samples and DNA collection. On entering the
study, fingerpricks from each child were taken for thick and
thin blood films and for DNA. The microscopic diagnosis of
malaria was based on examination of 100 high-power fields
of the thick film after staining with 3% Giemsa. Parasite
counts were calculated according to the WHO method,15 as-
suming 6,000 leukocytes/ml. Every child was allocated a
sheet of Whatman (Maidstone, United Kingdom) 3MM pa-
per (13 cm 3 10 cm) on which the blood spots were stored
prior to DNA extraction or hemoglobin isoelectric focusing.
The name, age, code number, and date of collection were
recorded in pencil on the appropriate sheet of Whatman
3MM paper. After collection, the blood spots were allowed
to dry before the sheets of paper were transferred into in-
dividual resealable polythene bags for shipping and long-
term storage at ambient temperature.
The DNA was extracted from the paper as previously de-
scribed.16 Briefly, a small portion of blood spot (approxi-
mately 3 mm 3 3 mm) was soaked for 10–20 min at room
temperature in a 1.5-ml microfuge tube containing 1 ml of
phosphate-buffered saline (PBS)/1% saponin (PBS 5 0.14
NaCl, 0.01 M sodium phosphate, pH 7.2). The PBS/1% sap-
onin was discarded and the DNA was extracted from the
paper by the addition of 150 ml of water and 50 ml of Chel-
ex-100 (Bio-Rad Laboratories, Hercules, CA) (made up to
20% [w/v] in water and adjusted to pH 9.5 with 1 M NaOH),
followed by boiling for 8 min. The Chelex was removed by
centrifugation and the supernatant was transferred to a an-
other microfuge tube. The DNA was then ready to use and
was stored at 2208C prior to amplification.
Polymerase chain reaction (PCR) amplification. The
sequences and relative positions of the primers are shown in
Figure 1. All primers were used at a concentration of 100
ng/ml. Amplification was carried out using a programmable
thermocycler (Omnigene; Hybaid, Teddington, United King-
dom).
Amplification was performed in two stages. The first
round, in a final volume of 25 ml, contained 5 ml DNA, 200
mM dNTPs, 13 Taq polymerase buffer containing 1.5 mM
MgCl2 and 1 unit of Amplitaq (Cetus, Branchburg, NJ). The
primers were TRAP1 and TRAP2. The cycling conditions
were as follows: two cycles of 1 min at 938C, 1 min at 378C,
and 2 min at 728C, followed by 35 cycles of 1 min at 938C,
1 min at 558C, and 2 min at 728C, with a final cycle of 1
min at 938C, 1 min at 558C, and 10 min at 728C. The reaction
was then diluted to 250 ml with sterile water and stored at
2208C until further use. If DNA had been purified from
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TABLE 1
RFLP analysis of thrombospondin-related adhesive protein*
Restriction enzyme site
Presence/Absence
Restriction fragment lengths
size (bp) and order
Bgl II
1 2
1 1
2 1
2 2
129, 1,509†
129, 1,090†, 419
1,219†, 419
1,638†
Afl II/Asp 718
1 2
1 1
2 1
2 2
351, 415, 872†
351, 33, 382, 872†
384, 382, 872†
766, 872
Ssp I
1 2
1 1
2 1
2 2
13, 248, 1,377†
13, 248, 963†, 414
13, 1,211†, 414
13, 1,625†
Taq I
1
2
926, 211†, 501
1,137†, 501
* For BglII, 1 2 indicates that the 59 BglII site is present and that the 39 site is absent.
The same rules apply in defining the presence or absence of the other restriction enzyme
sites. Details can be obtained by email or fax from the corresponding author (KJHR).
† These fragments can vary in size since they contain the region with repeats.
liquid blood as in the Gambian study,17 only a single round
of the PCR was found to be necessary. When using DNA
purified from blood or cultured parasites, we use primers
TRAP1A and 2A to obtain the diagnostic fragment sizes
shown in Table 1.
For restriction fragment length polymorphism (RFLP)
analysis, a second round of PCR was performed using the
primers TRAP1A and TRAP2A (Figure 1). Amplification
was performed as before but using 2 ml of diluted DNA from
the first round of amplification in a final volume of 100 ml.
Cycling conditions were as for the first round except that
the initial two cycles with annealing at 378C were omitted.
For repeat analysis, the second round of the PCR was
performed using primers TRAP17 and TRAP8 (Figure 1).
Amplification was performed as before using 1 ml of diluted
DNA from the first round of amplification in a final volume
of 20 ml containing 2 mCi of 35S-dATP (Amersham, Little
Chalfont, United Kingdom). Cycling conditions were as for
the RFLP second round except that the annealing tempera-
ture was decreased to 458C.
Certain DNA samples proved refractory to PCR amplifi-
cation under these conditions. First and second round am-
plifications were repeated using Taq extender (Stratagene,
Cambridge, United Kingdom) using the conditions recom-
mended by the manufacturer. The extension times were ex-
tended to 4 min for the first round PCR and the second round
RFLP PCR. This modification permitted the majority of the
remaining DNA samples to be amplified.
Amplification of merozoite surface protein 1 (MSP-1) by
the PCR was performed as previously described.18
Analysis by RFLP. The product from the second round
PCR amplification was digested with the restriction enzymes
Bgl II, Ssp I, Taq I, and Afl II following the manufacturer’s
(New England Biolabs, Beverly, MA) instructions. To aid
the Afl II analysis, the enzyme Asp 718 (Boehringer Mann-
heim, Lewes, United Kingdom) was added to those digests.
The Bgl II and Ssp I digests were resolved on 1.7% agarose
gels. The Taq I and Afl II/Asp 718 digests were resolved
using 1% agarose 1% NuSieve gels (FMC Bioproducts,
Rockland, ME). The sizes of the various restriction frag-
ments (Table 1) were used to define particular haplotypes.
The presence of a particular restriction enzyme site is rep-
resented by 1 and the absence by 2. Each combination of
1 and 2 was assigned a number. It should be noted that the
39 Bgl II and Ssp I sites are mutually exclusive. Haplotype
1 is defined as Bgl II 11, Ssp I 12, Taq I 1, Afl II 11
and so in abbreviated form haplotype 1 becomes
(1112111). Further details can be obtained by email
(krobson@hammer.imm.ox.ac.uk) or fax (44-1865-222-500)
from the corresponding author (KJHR).
Repeat polymorphism analysis. The samples for repeat
analysis were precipitated with ethanol. The DNA pellets
were washed with ethanol, air-dried, and resuspended in 3
ml of formamide dyes (80% deionzed formamaide, 13 glyc-
erol-tolerant gel buffer [0.089 M Tris, 0.0288 M taurine, 5.4
mM disodium EDTA], 0.1% [w/v] bromophenol blue, 0.1%
xylene cyanol FF). The samples were heated at 1008C prior
to loading on 5% Long Rangery (Flowgen, Rockland, ME)
gels containing 13 glycerol-tolerant gel buffer and 7 M urea.
Gels (31 cm 3 38.5 cm 3 0.4 mm) were electrophoresed at
60 W until the xylene cyanol FF had migrated to within 10
cm of the bottom of the gel. The M13mp18 sequencing lad-
ders were used as size markers on every gel. The PCR prod-
uct (TRAP17-TRAP8) from the laboratory line T9/96 was
used as an additional control on all gels, the product size
being 235 basepairs (bp). Gels were allowed to cool com-
pletely before drying and exposure to x-ray film for 1–7
days.
Sequencing of DNA. Direct sequencing of DNA products
was performed using a Sequenase PCR product sequencing
kit (U.S. Biochemicals, Cleveland, OH). Primers internal to
the PCR primers gave optimal sequencing results.
Experimental design and statistical analysis. Eighty-
five children with cerebral malaria were recruited during the
1992 malaria season. Each of these children was then age
matched with three children with mild malaria matched for
age and place of residence (locality). A total of 337 samples
were analyzed. Yates’ chi-square test (or Fisher’s exact prob-
ability test when needed) was used for the analysis of prev-
alence rates, and the Kruskall-Wallis test was used for the
analysis of age, parasite counts, and antibody levels.
Phylogenetic analysis. Networks19 were constructed se-
quentially by splitting the data, restriction enzyme site by
restriction enzyme site. This was performed manually. Splits
are represented by branches between haplotypes, each of
which represents a change in a restriction enzyme site. Each
haplotype was represented as a circle containing the haplo-
type number. The haplotypes were simplified to the number
only, with all versions with repeats being pooled.
Hemoglobin isoelectric focusing. Isoelectric focusing
was performed using the Resolve System Hemoglobin kit
(Isolab, Mechelen, Belgium). Hemoglobin (Hb) for analysis
was eluted from a single dry blood spot from the same sheet
of Whatman 3MM paper used for parasite DNA extraction.
Samples were analyzed for the presence of Hb A, Hb S, and
Hb C.
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RESULTS
Sequence analysis of a small region (200 bp) of the TRAP
gene from six isolates from Mali showed that we needed an
approach that would allow us to group related parasites
based on their TRAP gene sequence and that would save on
the expense and workload associated with sequencing. We
therefore chose to perform a haplotype analysis on the gene,
examining what we believed to be four polymorphic restric-
tion enzyme sites throughout the gene. Nucleotide changes
at these polymorphic restriction enzyme sites all result in
amino acid changes. The restriction enzymes chosen were
Bgl II, Ssp I, Taq I, and Afl II.
Polymorphisms associated with the enzyme Bgl II. Our
earlier detailed sequence analysis showed that there were
two Bgl II sites in the TRAP gene (Figure 1).11 The first, at
the 59 end of the gene, appeared not to be polymorphic,
whereas the second, towards the 39 end of the gene, clearly
was. Analysis of these samples from Mali showed that both
59 and 39 sites were polymorphic. Direct sequencing across
the region containing the 59 Bgl II site in samples that ap-
peared to lack the site demonstrated that there was a nucle-
otide change resulting in the amino acid change Leu49 to
Val49, which corresponds to C145G in the DNA sequence.
This Bgl II site was present in 96.4% of the chromosomes
analyzed.
The 39 Bgl II site and what we describe as the 39 Ssp I
site are mutually exclusive. The presence of the 39 Bgl II
site was detected only in 0.6% of our sample chromosomes,
whereas the Ssp I site was much more common (37.2%).
The most common situation was the intermediate nucleotide
sequence in which neither site was present (62.2%).
Polymorphisms associated with the enzyme Ssp I. In
our study of the TRAP gene from different laboratory iso-
lates and clones we found that there was a polymorphic 59
Ssp I site associated with DNA encoding amino acids 90,
91, and 92. The original sequence for the TRAP gene was
from the Thai clone T9/96 in which the DNA encodes the
amino acid motif Val90Asn91Val92. In three samples taken
from patients in the Gambia in 1988 the same motif was
present.11 Sequence analysis of three samples from our Mali
survey also showed the same motif to be present. This motif
is associated with the absence of the Ssp I site. Another
related amino acid motif is also associated with the lack of
this site, Ala90Ser91Val92, and is found in two lines of African
origin, 3D7A and 7901 (Palo Alto/Uganda). Two nucleotide
changes are associated with this new amino acid motif.
The presence of this Ssp I site is associated with two re-
lated amino acid motifs, Ala90Asn91Ile92 and Leu90Asn91Ile92,
which differ from the Val90Asn91Val92 by two and three nu-
cleotide changes, respectively. The presence of the 59 site
was only detected twice in our survey. Since these samples
were not sequenced, we do not know which of the two pre-
viously observed amino acid motifs were present. The pres-
ence of the 59 Ssp I site and the 39 Bgl II site seem to be
more common in parasites of non-African origin.
Polymorphisms associated with the enzyme Taq I. A
different history appears to be associated with the Taq I site.
If the site is absent, the amino acid motif encoded by the
DNA sequence is Ser311Ser312Val313Gln314; if the site is pres-
ent, then the amino acid motif is Phe311Ala312Val313Glu314.
These sequences differ by three nucleotides. The Taq site is
absent in laboratory lines T9/96 and 7G8 but is present in
all the others sequenced to date. The presence of the Taq I
site appears to be in linkage disequilibrium with the
Phe311Ala312Val313Glu314 motif since no intermediary se-
quences have been seen. This cannot be said for the se-
quence changes associated with the 59 Ssp I site. The Taq I
site was present in 66.7% of our sample chromosomes.
These data suggest that either this mutationseries of muta-
tions may have arisen independently in different continents
or else is a particularly ancient mutation that has been found
in samples from Thailand, Mali, and Brazil. It is interesting
to note that this series of amino acid changes follows the
Arg307Gly308Asp309 motif.
Polymorphisms associated with the enzyme Afl II.
There are two Afl II sites in the gene that are 33 bp apart.
Loss of the second of these is associated with a change at
amino acid position 134 of Ser to Thr. The first was not
known to be polymorphic until we undertook this study. Di-
rect sequencing across the region demonstrated that loss of
the 59 site is associated with a Ser to Asn change at amino
acid position 123 and corresponds to the nucleotide change
G367A. All four combinations were observed in our survey.
The frequencies were as follows: 11 5 6.2%, 12 5 49.6%,
21 5 18.1%, and 22 5 26.1%.
Haplotype analysis. Restriction enzyme analysis of the
PCR-amplified TRAP gene permitted us to assign the gene
to one of 96 possible haplotypes. It also allowed us to see
whether mixed infections were present. It was not possible
to get a complete result in all cases. Some samples (17 of
337) appeared refractory to PCR analysis regardless of
whether human or parasite primers were tried. These sam-
ples were excluded from our analysis. In other cases in
which more than two haplotypes were present, we could not
always assign haplotypes to particular parasite chromo-
somes. In certain other samples, we were unable to generate
data for all the restriction sites analyzed. We did not discard
these data because they were still useful in assigning fre-
quencies to particular RFLPs. We were able to assign num-
bered haplotypes to 319 chromosomes. Of the 96 possible
numbered haplotypes, we observed 20. The results are given
in Table 2.
Further analysis was possible due to our earlier observa-
tions11 that the TRAP gene has a small repeating three amino
acid motif inserted after amino acid 352. The PCR amplifi-
cation across this region permitted a more detailed analysis
of the parasites in our survey. Values varying from no extra
repeats up to 16 were observed (Table 2). In many instances,
these could be assigned to certain haplotypes (Table 2). We
never observed a chromosome with either 11 or 13 extra
repeat units. It should be noted that TRAP genes with repeats
of more than 10 extra units were rarely observed (Table 2).
In certain cases of mixed infections, we could not assign a
repeat value to a given haplotype number; these have un-
assigned repeat numbers (Table 2). The repeat analysis
proved very useful in analyzing mixed infections. The ability
to leave the gels analyzing repeat values exposed to the x-
ray film for several days permitted us to see mixtures that
were not apparent using staining with ethidium bromide. Us-
ing repeat analysis alone we were able to examine the pro-
portion of parasites present in mixed infections. Applying
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TABLE 2
Summary of the observed thrombospondin-related adhesive protein haplotypes in Mali*
Haplotype
number
Repeat letter and corresponding number of extra repeats
A
0
B
1
C
2
D
3
E
4
F
5
G
6
H
7
I
8
J
9
K
10
L
11
M
12
N
13
O
14
P
15
Q
16
Unas-
signed Total
3
25
26
27
28
1
2
8
8
2
1
8
2
8
4 2
1
2
1
1
1
2 1 1
1
2
12
5
4
1
5
41
15
18
29
30
31
32
41
10
1
3
1
5
1
2
3
1
6
2
2
1
2
21
4
7
4
42
43
44
45
46
13
4
2
1
6
10
6
5
3
8
10
4
3
2 22
8
2
1 3
1
2
1
1
1
1
3
1 1
1
2
14
6
7
2
8
80
24
30
6
25
47
48
74
75
90
10
1
1
3
3
1
3 1 1
2 1
1 1
1 1
1
3
1
19
10
3
1
3
Total
Frequency of
extra repeat units
73
118
70
111
24
42
6
12
38
67
3
5
11
26
4
8
4
13
1
5
5
5 0
1
1 0 2
1
3
1
1
77 319
419
* The haplotype number down the left hand side refers to the combination of restriction enzyme site. Haplotype 42 is 1222112. The row of letters across the top is the code applied
to the number of repeating units, A being the baseline found in T9/96. Along the very bottom of the table is the frequency of the extra repeat units including those where it was not possible
to assign a complete haplotype.
TABLE 3
Thrombospondin-related adhesive protein haplotypes of common
laboratory clones/lines of Plasmodium falciparum
Line/clone Haplotype Geographic origin
T9/96
HB3A
3D7A
7G8
30A
34A
42F
37B
Thailand
Honduras
West Africa
Brazil
Dd2
7901
K1
FCR3 group
33A
42A
1A
1A
Indochina
Uganda
Thailand
?
this approach, 180 children had single infections, 80 had
two, 17 had three, three had four, two had five, and one had
six infections. Combining the repeat analysis with the hap-
lotype information, we were able to assign complete TRAP
haplotypes for 242 chromosomes. We observed 74 of 1,440
of the possible combinations based on repeat and RFLP anal-
ysis (Table 2).
The degree of observed variation in the TRAP gene pre-
cluded the numbers necessary to see whether parasites pres-
ent at the start of our study period were absent at the end.
It should be noted that the three TRAP genes sequenced
from children in the Gambia with malaria infections in 1988
used the nomenclature 42B, 42C, and 42D. Haplotype 42
was the most common in our survey. The numbers present
also precluded any correlation with age, hemoglobin status,
or disease severity.
The haplotypes of certain, well-known, laboratory lines
that are from different geographic locations are given in Ta-
ble 3. With the exception of haplotype 30, we did not ob-
serve any of the haplotypes of other known laboratory lines
of non-African origin. Line FCR3, which has been thought
to have been of African origin, is haplotype 1, as is K1, a
well-known Thai strain. We did not observe haplotype 1 in
our study. Line FCR3 differs from haplotype 42 by a mini-
mum of three and from haplotype 3 (we observed haplotype
3 once in our study) by a minimum of one restriction enzyme
sites, respectively. We have previously seen haplotype 30 in
Thailand (T9/96); this may be a more global haplotype. It is
interesting to note that one of the ways haplotype 30 differs
from haplotype 42 is by the Taq I site, which differentiates
the two sequences around the Arg-Gly-Asp motif. Both
T9/96 and 7G8 (Brazilian) lack the Taq I site next to the
Arg-Gly-Asp motif. Changes in this motif may reflect poly-
morphisms in the mosquito or human host. These data sug-
gest that such a haplotyping system reflects the geographic
differences between P. falciparum parasites.
Phylogenetic analysis. The network for the haplotypes in
the TRAP gene is shown in Figure 2. Although networks
are unrooted (having no obvious common ancestor), the neu-
tral theory of molecular evolution implies that all else being
equal, the more common haplotypes are likely to be older.
With the immune pressure on this malaria gene, this may
not be true.
DISCUSSION
Unlike other malaria vaccine candidates, TRAP has not
been studied in detail in naturally occurring infections. If
TRAP is to be considered seriously as a component of a
subunit vaccine, we need to understand the basis of natural
sequence variation so that this information is reflected in the
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FIGURE 2. Phylogenetic network of thrombospondin-related protein haplotypes. Each numbered haplotype is represented by a circle con-
taining the haplotype number, in which the area of the circle is proportional to the observed frequency of the haplotype. The small filled circle
represents a theoretical intermediate node that could be removed to resolve B5 into two distinct events: the result would then be virtually a
simple one-step connected network. Splits are represented by lines connecting the haplotypes, labeled for the restriction site changes that
generated the split: A for Afl II, B for Bgl II, S for Ssp I, and T for Taq I. The subsequent 5 or 3 refers to whether it is at the 59 or 39
restriction enzyme site. The four-way conflict (S3T/A5/A3) is represented by placing haplotypes at the vertices of a four-dimensional cube, in
which the fourth dimension (A3) is represented by connecting the vertices of two three-dimensional cubes. Haplotypes occur at all eight
vertices. Certain haplotypes were observed 10 times or less (3, 25, 29, 31, 32, 41, 46, 48, 74, and 90). The majority of haplotypes occurring
10 or more times differ from haplotype 42 by one or two steps. Equally, some of the haplotypes that were observed infrequently differ from
42 by only one step. Therefore, certain evolutionary pathways may be preferred. * 5 B51 B31 S51 S32 T1 A52 A31.
sequences incorporated into such a vaccine. In this study, we
have extended our earlier work on sequence variation, ex-
amining material from a case-control study in Mali. From
our earlier work,11 there was a suggestion that certain regions
of the molecule could tolerate point mutations and insertions
whereas others could not. We have detected two new RFLPs
that corresponded to amino acid changes that have increased
the power of our analyses. We have applied these observa-
tions to develop a PCR-based haplotyping system for TRAP
that not only examines specific amino acid changes but also
detects changes in the size of the small repeat region. This
combinatorial approach allowed us potentially to identify up
to 1,440 TRAP haplotypes. This method could easily be ex-
tended by examining more polymorphic restriction enzyme
sites, e.g., Fok I. The restriction enzyme sites detected nu-
cleotide changes that correlated with amino acid changes.
We were able to assign complete haplotypes to 242 chro-
mosomes and in doing so detected 74 of 1,440 possible hap-
lotypes. Limited DNA sequence analysis suggests that this
is an underestimate of the sequences in circulation. Together
our data suggest that the molecule is under significant im-
munologic pressure. This may be due to a combination of
factors including sporozoite exposure and the expression of
TRAP both by mature sporozoites and by parasite infected
red blood cells.
Using the numbered haplotypes, number 42 predominated.
This haplotype had been observed in our earlier study using
samples from The Gambia taken in 1988.11 Clones 3D7A
and 7901, parasites also of African origin, are haplotype 42
by this system, but are known to differ both from each other
and the isolates in this study at other positions in TRAP. The
next most common haplotypes differed by one or two re-
striction enzyme sites from haplotype 42. Haplotype 3, at
the other end of the spectrum, was observed only once and
on its own. It differs from haplotype 42 at four restriction
enzyme sites. It was found in a 12-year-old child with mild
malaria living in an urban area. Where mixed infections of
P. falciparum were present and haplotypes could be com-
pletely assigned, haplotype 42 was present with closely re-
lated haplotypes, and no particular combination was seen
more frequently. This is in part due to the large number of
haplotypes that were present in the study area, and therefore
it was difficult to obtain statistically significant results for
many of the observations. No particular TRAP haplotype or
polymorphism was associated with parasites from children
who died of severe malaria.
The system was used to analyze mixed infections in chil-
dren with mild and severe malaria. It gives a minimum es-
timate of the number of parasites present in any mixture.
When a TRAP haplotype was used as a marker to define
mixed infections of P. falciparum, 49.3% of the children
with severe malaria and 51.1% of the children with mild
malaria had mixed infections of P. falciparum. The number
of TRAP haplotypes present varied from one to six when
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the repeat polymorphism was used on its own. Studies from
Thailand,20, 21 where parasites were cloned from particular
patients, found six and six clones, respectively. Using mono-
clonal antibodies against three polymorphic blood-stage an-
tigens, Conway and others were able to detect up to four
clones per isolate.22 They found a mean of two P. falciparum
clones in samples from patients with malaria in The Gambia.
We were therefore not surprised to see this range of mixed
infections of P. falciparum in children from Mali, another
West African country. It is interesting to note that we were
using a genetic marker that is predominantly associated with
the sporozoite, whereas these other studies were looking at
markers whose main biological activity was in blood-stage
infections. These blood-stage proteins such as MSP-1 are
much more subject to selective pressures by the host than a
sporozoite protein such as TRAP.
Repeat length appears to be independent of TRAP hap-
lotype. The significance of the small tandem repeat in TRAP
is not understood. It occurs in the part of the molecule where
significant repeating motifs are found in SSP2,23, 24 P. bergh-
ei TRAP,25 and TRAPs from P. vivax, P. knowlesi, and P.
gallinaceum,26 and is also the region where the TRAP mol-
ecules differ most from each other. Dual mixed infections
based on TRAP analysis tended to be due to related parasite
haplotypes differing either by repeat length or one restriction
enzyme site. The high degree of sequence polymorphism
precluded statistical analysis for this observation.
We have analyzed the data from the case-control study
looking at levels of parasitemia, disease severity, sickle cell
status, age, month of infection, and geographic location (ur-
ban, periurban, and rural) with relation to TRAP polymor-
phisms/haplotype. For statistical purposes, haplotypes were
simplified and analyzed either for repeat letter or haplotype
number. The sample size, together with the number of hap-
lotypes and the number of comparisons, made were such that
no statistically significant results were obtained. A further
study would be required to increase the sample size and also
to look at parasites occurring subsequently in this group of
children.
The parasite samples came from a wide variety of children
from one to 12 years of age living predominantly in urban
and periurban regions of Bamako, Mali. Haplotype analysis
revealed that 50% of the children in this study had mixed
infections of P. falciparum, regardless of whether they had
mild or severe disease. This suggests that if other markers
are combined in a similar analysis, the vast majority of chil-
dren will be shown to have mixed infections. It is difficult
to say whether this is a characteristic of the children in our
study or a country where malaria is hyperendemic or wheth-
er it relates to the number of infectious bites per child per
year. Mixed blood feeding by mosquito vectors from more
than one individual is unusual,27 and therefore mating will
mostly occur between parasites acquired from a single in-
dividual. This suggests that the children in our study who
clearly had multiple infections had been bitten on more than
one occasion by an infected mosquito and very possibly had
failed to clear earlier infections. This result is not unexpected
since the study was carried out during the main malaria
transmission season in Bamako.
Based on our TRAP analysis, only two pairs of siblings
had single infections, suggesting the possibility that they
might have been bitten by the same mosquito. A second
gene, MSP-1, was analyzed in these four children. The two
children infected with parasite TRAP haplotype 47A, a hap-
lotype that was seen 10 times, had MSP-1 genes that were
clearly different. The two children with a parasite having
TRAP haplotype 42I, a haplotype that was observed three
times, had MSP-1 genes that could not be distinguished us-
ing the block 3 repeat polymorphism. This was the only
instance observed where there was any suggestion that chil-
dren might have been infected by parasites from the same
mosquito.
A series of studies looking at sequence variation have
been carried out for other potential malaria vaccine constit-
uents. These include the sporozoite stage of the parasite life-
cycle, the circumsporozoite protein, and the two blood-stage
merozoite surface proteins MSP-1 and MSP-2.28–33 These
proteins differ from TRAP in that they all contain major
repeating epitopes or blocks of repeats. The sequence vari-
ation in these antigens has been examined in a variety of
ways that have included RFLP and hybridization analysis of
PCR products, as well as sequencing of PCR products both
cloned and uncloned.
The consequences of these studies are that for subunit
malaria vaccines to be effective, the major variants of the
different components for a given area may be required. This
may be more important in Africa where more variants of the
different protein components have been reported. This may
also apply to regions of the world where there are large
migrant populations such as on the Thai-Burmese border.
The major influence of hemagglutinin and neuraminidase se-
rotypes determines which major types are used in flu vac-
cines on an annual basis. As with influenza, it must be as-
sumed that host immune responses are responsible for the
observed sequence variation.
The structure of TRAP has yet to be determined so it is
difficult to understand the significance of these sequence
changes. From sequence alignment, the extracellular portion
of TRAP can be divided into three domains. The first domain
shares significant sequence similarity with the I domain of
the a subunit of the integrin CR3 (CD11b/CD18).34 The ma-
jority of RFLPs that we have examined in this study are in
this region of the molecule. All of these amino acid substi-
tutions can be regarded as conservative and as such would
not alter the structure of this part of the molecule signifi-
cantly and probably the function, but would be sufficient to
alter the antigenicity. The second domain of TRAP contains
the sulfatide-binding domain and has been found both in our
earlier11 and this study to be conserved. It is interesting to
note that one of the major cytotoxic T cell epitopes for a
large number of Europeans is found in this conserved part
of the molecule.10 The third domain contains the polymor-
phism associated with the Arg-Gly-Asp motif, which can be
considered to alter the hydrophobicity of the flanking se-
quence. The small tandem repeat is also found in this region
as is the complex Bgl II/Ssp I polymorphism.
The fact that the same point mutations are found in par-
asites from different geographic locations suggests that these
point mutations can arise independently and become fixed
in different populations, which is suggestive of selective
pressure. Each sporozoite is only exposed to the host’s im-
mune system for a short time but the numbers of sporozoites
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an individual is exposed to over a lifetime is large. This is
clearly sufficient pressure for TRAP variants to evolve and
be selected. However, it should be pointed out that since the
same point mutations are found in different geographic lo-
cations, this suggests that structural constraints are important
and may in fact limit the repertoire of variants found. The
majority of the point mutations give rise to conservative
amino acid substitutions and such changes are unlikely to
give rise to major alterations in particular epitopes. It is also
possible that this variation in the form of point mutations
occurred at a bottleneck during evolution of the parasite be-
fore the spread to different parts of the world.
In playing a game of chance such as a slot machine or
throwing four dice, the chance of getting four identical sym-
bols or throwing four sixes occurs infrequently but at a fixed
odds. Most of the time a random combination of numbers
or symbols occurs and this is what appears to be the case
with the polymorphic sites in TRAP. At present we do not
know whether certain combinations occur more often by
chance alone or whether immunologic pressure is the selec-
tive force behind this. Thrombospondin-related adhesive
protein is continually evolving. This is shown by applying
phylogenetic analysis to the system (Figure 2).19 This is the
first report of this method being applied to sequence varia-
tion in malaria. A two-dimensional approach has been tried
with MSP-2 to try and identify geographic clustering.35 Ap-
plying phylogenetic analysis to TRAP sequence variation
suggests that there is fluidity in the system that would not
be recognized using two-dimensional approaches. This
method does permit clustering and is demonstrated by the
fact that the most common haplotype, haplotype 42, differed
from the majority by one restriction enzyme site using this
classification system. Immunity may result as a consequence
of being exposed to a certain number of permutations and
combinations of TRAP and other antigens. This would ex-
plain why immunity develops with age after repeated ex-
posure to parasite infections.
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